Atopic Dermatitis
Chronic, relapsing inflammatory skin disease driven by type 2/Th2 immune dysregulation and epidermal barrier dysfunction, presenting as pruritic, eczematous lesions; the most common chronic inflammatory skin disease in both adults and children.
Phase 1/2 and later readouts in Atopic Dermatitis, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Total attributable cost
$98.8B
$4,979/patient
Drug spend
$23.2B
$1,168/patient
All severities, self-reported diagnosis (2024 NHIS) · US